BCM
KZR

BML Capital Management’s Kezar Life Sciences KZR Stock Holding History

BML Capital Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-720,787
Closed -$5.35M – 19
2026
Q1 		$5.35M Hold
720,787
– – 3.43% 8
2025
Q4 		$4.53M Hold
720,787
– – 3.92% 7
2025
Q3 		$2.81M Buy
720,787
+85,604
+13% +$351K 2.57% 9
2025
Q2 		$2.91M Buy
635,183
+227,045
+56% +$973K 2.2% 11
2025
Q1 		$1.99M Buy
408,138
+359,470
+739% +$2.18M 1.61% 13
2024
Q4 		$327K Buy
+48,668
New +$363K 0.2% 20

BML Capital Management's KZR Position: Q2 2026 in Review

BML Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 720,787 shares — an estimated $5.35M sold.

BML Capital Management first reported a position in KZR in Q4 2024 and held it in 6 quarters. The position peaked at $5.35M in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • BML Capital Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • BML Capital Management sold 720,787 Kezar Life Sciences shares in Q2 2026, an estimated $5.35M.
  • BML Capital Management first reported a position in Kezar Life Sciences in Q4 2024 and held it in 6 quarters.
  • BML Capital Management's Kezar Life Sciences position peaked at $5.35M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on BML Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.